News Agency
Men's Weekly

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints

  • Written by PR Newswire
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints
  • CBL-514 is the first product to treat cellulite at the raised areas.
  • Currently, there is no effective and safe cellulite treatment on the market. The global market for cellulite treatment is estimated to expand to $7.37 billion in 2034.
  • CBL-0201EFP Phase 2 study demonstrated CBL-514 statistically significant efficacy in reducing cellulite severity...

Read more: Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary...

3PL Companies Powering Efficient Logistics And Scalable Business Growth

Behind every smooth online order and timely delivery, there’s often an invisible engine working tirelessly in the background. That engine is powered by 3PL companies, quietly orchestrating storage, packing, and shipping so businesses can focus on what they do best... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion